Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-13

Clinical Trial Update: "CHANGE COVID-19 Severity" [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating changes in COVID-19 severity was terminated; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: COVID-19 Infection | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-11-13